Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
40
YI Quote, Financials, Valuation and Earnings
Last price:
$7.57
Seasonality move
:
-6.34%
Day range:
$7.40 - $7.55
52-week range:
$4.15 - $12.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.03x
P/B ratio:
--
Volume:
2.8K
Avg. volume:
11K
1-year change:
-29.53%
Market cap:
$65.4M
Revenue:
$2B
EPS (TTM):
-$6.53
Earnings Data
Next earnings date for YI
Aug 29
2025
Most recent earnings per share
-$5.50
Missed by $5.50
(Jun 19/2025)
Consensus Estimate
--
(Jun 19/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
YI Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $541.4M | -- | -- | -- | -- |
| 08/29/2025 | Q2 | $514.9M | -- | -- | -- | -- |
| 06/19/2025 | Q1 | $530.5M | $485.1M | -$5.50 | -- | -- |
| 03/20/2025 | Q4 | $546.5M | $534.8M | -$0.31 | -- | -- |
| 11/28/2024 | Q3 | $524.3M | $502.9M | -$0.28 | -- | -- |
| 08/29/2024 | Q2 | $478.6M | $476.1M | -$0.44 | -- | -- |
| 05/23/2024 | Q1 | -- | $493.1M | -$0.22 | -- | -- |
| 03/21/2024 | Q4 | -- | $570.8M | -$3.45 | -- | -- |
| 11/30/2023 | Q3 | -- | $506.5M | -$1.53 | -- | -- |
| 08/24/2023 | Q2 | -- | $496.2M | -$1.94 | -- | -- |
| 06/15/2023 | Q1 | -- | $540.1M | -$0.56 | -- | -- |
| 03/23/2023 | Q4 | -- | $583.1M | -$1.94 | -- | -- |
| 12/01/2022 | Q3 | -- | $488.8M | -$1.69 | -- | -- |
| 08/25/2022 | Q2 | -- | $459.5M | -$1.72 | -- | -- |
| 06/16/2022 | Q1 | -- | $469.2M | -$2.08 | -- | -- |
| 03/17/2022 | Q4 | -- | $540.8M | -$2.09 | -- | -- |
| 11/19/2021 | Q3 | -- | $516.7M | -$4.69 | -- | -- |
| 08/27/2021 | Q2 | -- | $468M | -$5.94 | -- | -- |
| 05/19/2021 | Q1 | -- | $399.9M | -$2.74 | -- | -- |
| 03/18/2021 | Q4 | -- | $398.6M | -$2.38 | -- | -- |
| 11/19/2020 | Q3 | -- | $341.2M | -$1.91 | -- | -- |
| 08/20/2020 | Q2 | -- | $228.7M | -$1.58 | -- | -- |
| 05/21/2020 | Q1 | -- | $225.7M | -$2.18 | -- | -- |
| 12/31/2019 | Q4 | -- | $191.3M | -$2.73 | -- | -- |
| 09/30/2019 | Q3 | -- | $158.3M | -$2.14 | -- | -- |
| 06/30/2019 | Q2 | -- | $122.9M | -$1.79 | -- | -- |
| 03/31/2019 | Q1 | -- | $97.1M | -$2.16 | -- | -- |
| 12/31/2018 | Q4 | -- | $80.6M | -$2.23 | -- | -- |
| 09/30/2018 | Q3 | -- | $73.1M | -$4.11 | -- | -- |
| 06/30/2018 | Q2 | -- | $62.9M | -$1.64 | -- | -- |
| 03/31/2018 | Q1 | -- | $51.9M | -$0.82 | -- | -- |
| 12/31/2017 | Q4 | -- | $41.7M | -$1.21 | -- | -- |
| 09/30/2017 | Q3 | -- | $37.3M | -$1.15 | -- | -- |
111 Earnings Questions
-
How Much did 111 Generate in Revenue Last Quarter?
111 reported $485.1M worth of top line sales in its most recent quarter.
-
Did 111 Beat Earnings Last Quarter?
111 announced earnings per share of -$5.50 which represents a miss of analyst forecast a -- per share.
-
Is 111 Profitable?
111 reported $26.8M that represents $3.10 per share over the last quarter.
-
What is the Analyst Consensus for 111 EPS Next Year?
111's earnings are forecast to grow from -$1.06 per share to -- per share next year representing an increase of --.
-
When is 111's Earnings Date?
111's next earnings date is August 29, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
72
SBET alert for Jul 18
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
